Lemtrada At A Glance
If you’ve been considering your treatment options for relapsing MS, it may be time for you and your healthcare provider to discuss LEMTRADA.
5 THINGS YOU SHOULD KNOW ABOUT LEMTRADA:
- LEMTRADA is a prescription infusion medicine used to treat adults with relapsing multiple sclerosis (MS). It’s generally used in people who have tried 2 or more MS medicines that haven’t worked well enough.
- LEMTRADA is a relapsing MS medication that is administered in 8 doses over two years—on 5 consecutive days in round 1 and, one year later, on 3 consecutive days in round 2. You and your healthcare provider may decide that you need one or more additional rounds of treatment. If so, this would occur at least 1 year after your last round and would consist of 3 treatment days in a row. For all rounds, you will be given certain medications prior to treatment.
- You will be monitored monthly starting after your first infusion and continue to monitor until 4 years or longer after your last round of treatment. Because of the risks of autoimmunity, infusion reactions, and some kinds of cancers, LEMTRADA is only available through a Risk Evaluation and Mitigation Strategy (REMS) program.
- LEMTRADA was studied vs Rebif® (interferon beta-1a) in a 2-year study. Take a look at the clinical study results.
- LEMTRADA offers all patients additional resources and support, including financial assistance for eligible patients, through the MS One to One® program.
HEAR WHAT LEMTRADA PATIENTS ARE SAYING
Real life experiences can be informative. Here's what people who have tried LEMTRADA
have to say.
To hear more from people taking LEMTRADA, visit our patient videos page.